Pfizer Inc (PFE) 34.93 $PFE Final Glance:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 34.93 $PFE

Final Glance: Pharmaceuticals companies
AP - 2 hrs 10 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)

Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 26 mins ago
Pfizer Inc.'s (PFE) phase III study on inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia (ALL) met the first primary endpoint.
BIIB: 423.57 (+1.46), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10), AMGN: 169.10 (+0.64)

Beat The Market Twice: 5 Top Dividend Stock Winners
at Investor's Business Daily - Wed Apr 22, 4:24PM CDT
Dividend-paying companies aren't usually known for their stock price performance, but these five Dividend Leaders are beating the market this year -- and offer big yields, too. All have bagged double-digit gains, compared with about a 6% advance for...
RAI: 76.04 (+0.43), UN: 44.06 (-0.59), WU: 20.80 (+0.10), PFE: 34.93 (+0.04), LO: 70.77 (-0.23), MSFT: 42.99 (+0.36), AAPL: 128.62 (+1.71)

Midday Glance: Pharmaceuticals companies
AP - Wed Apr 22, 12:39PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)

Capricor cell therapy candidate an Orphan Drug for Duchenne muscular dystrophy
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:56AM CDT

ROSG: 3.83 (-0.20), CAPR: 7.50 (+0.76), BMRN: 121.08 (-0.16), RNA: 18.65 (unch), PFE: 34.93 (+0.04), SRPT: 13.52 (+0.04), PTCT: 70.98 (unch), SMMT: 11.00 (-0.59)

Pfenex Inc. Shifts Focus In-House To Develop Biosimilar To Betaseron
Christopher Stoehr - at Seeking Alpha - Wed Apr 22, 11:10AM CDT

PFE: 34.93 (+0.04), PFNX: 15.12 (+0.42), HSP: 87.80 (+0.04)

Uptrend Call Working As Pfizer Stock Rises 17.5% (PFE)
Comtex SmarTrend(R) - Wed Apr 22, 9:59AM CDT
SmarTrend identified an Uptrend for Pfizer (NYSEFE) on October 30th, 2014 at $29.69. In approximately 6 months, Pfizer has returned 17.48% as of today's recent price of $34.88.
PFE: 34.93 (+0.04)

Early Glance: Pharmaceuticals companies
AP - Wed Apr 22, 9:25AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 100.43 (+0.13), BAX: 70.38 (+0.33), PFE: 34.93 (+0.04), BMY: 66.60 (-0.21)

A Discussion Of Amgen's Q1 Results, With Updates On Its Pipeline
DoctoRx - at Seeking Alpha - Wed Apr 22, 8:28AM CDT

PFE: 34.93 (+0.04), AMGN: 169.10 (+0.64), LLY: 72.30 (+0.09), BMY: 66.60 (-0.21), SNY: 51.59 (+0.03), REGN: 472.63 (+9.41), HSP: 87.80 (+0.04), CELG: 115.54 (+0.72)

Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
George Budwell, The Motley Fool - Motley Fool - Wed Apr 22, 7:11AM CDT
Biotechnology is rapidly giving rise to ground-breaking new medicines that are dramatically changing the outlook for devastating diseases such as hepatitis C, malaria, and, perhaps most astoundingly, cancer. This innovation boom has gone hand in hand...
AGEN: 6.08 (+0.21), ADXS: 22.18 (+0.10), PFE: 34.93 (+0.04), MRK: 57.69 (+0.03), AZN: 73.35 (+0.65), BMY: 66.60 (-0.21), FPRX: 24.07 (-0.85)

Healthcare's Health Scanner: Complementary Research on Pfizer, Mylan, Teva Pharmaceutical, Bristol-Myers Squibb, and Merck & Company
PR Newswire - Wed Apr 22, 7:00AM CDT
Editor Note: For more information about this release, please scroll to bottom.
MRK: 57.69 (+0.03), PFE: 34.93 (+0.04), MYL: 72.40 (-1.67), TEVA: 63.01 (-1.15), BMY: 66.60 (-0.21)

Most active New York Stock Exchange-traded stocks
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
T: 32.86 (+0.20), GE: 26.91 (+0.29), AA: 13.57 (+0.05), RF: 9.73 (+0.15), CHK: 14.41 (-0.16), PFE: 34.93 (+0.04), C: 53.10 (+0.62), HAL: 47.11 (+0.06), BAC: 15.74 (+0.24), CSX: 36.26 (+0.91), VZ: 49.57 (+0.40), RAD: 8.32 (+0.39)

Merck KGaA-Pfizer Start First Cancer Registration Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 3:50PM CDT
Merck KGaA (MKGAF) and Pfizer Inc. (PFE) announced the commencement of a phase III study on avelumab in comparison with Taxotere for non-small cell lung cancer.
SHPG: 253.58 (+3.70), PFE: 34.93 (+0.04), HZNP: 30.96 (+0.10)

Pharma Spends Big On M&A In Q1 As Teva Pulls Trigger On Mylan
EP Vantage - Seeking Alpha - Tue Apr 21, 2:25PM CDT
The pharma and biotech buying spree showed no sign of abating in the opening months of 2015, with $69bn committed across 62 deals in the first quarter, EvaluatePharma data show. And with Teva (NYSE: TEVA ) confirming its interest in ...
AGN: 240.22 (+2.88), VRX: 206.93 (-3.92), ACT: 295.22 (+0.69), PFE: 34.93 (+0.04), MYL: 72.40 (-1.67), ABBV: 64.52 (+0.91), TEVA: 63.01 (-1.15)

Pfizer says leukemia drug met 1 goal in study
AP - Tue Apr 21, 11:06AM CDT
NEW YORK (AP) — Pfizer said Tuesday that an experimental blood cancer drug met one of its two goals in a late-stage trial, as patients who were treated with the drug were more likely to have a complete remission.
PFE: 34.93 (+0.04)

Pfizer's Xalkori tagged a Breakthrough Therapy for type of lung cancer
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 9:38AM CDT

PFE: 34.93 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 7

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Goddess Maintenance Co. Eyes BeautyMatter Award

Updated Category News Views 5

Challenging the Haircare Norm with Confidence Goddess Maintenance Co. doesn't just draft a fresh play in the beauty industry playbook—it's ripping out the old pages and setting a new standard. This ain't your granny's haircare game anymore, folks. They're up for a 2026 BeautyMatter Award, a nod to their gut-busting innovation in the conditioner category with their star...

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 5

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 6

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading

Top 5 Most Recently Viewed Articles

Enhancing Patient Engagement: athenahealth's Findings on Digital Tools

Updated Category News Views 132

Understanding the Impact of Digital Engagement in Healthcare In today's fast-paced healthcare environment, the importance of patient engagement has never been clearer. Recent research from athenahealth, a prominent provider of network-enabled software and services for medical practices, sheds light on how digital engagement tools can significantly enhance healthcare...

Continue Reading
Planisware's Latest Share Capital Update for November 2025

Updated Category News Views 185

Comprehensive Overview of Planisware's Share Capital Every month, Planisware offers insightful updates on its share capital, helping investors and stakeholders understand the structure and dynamics of the company. This article focuses on the crucial information released for November 2025, detailing the total number of shares and the voting rights associated with them....

Continue Reading
Automotive Fuse Market Growth Driven by Electric Vehicle Demand

Updated Category News Views 146

Understanding the Automotive Fuse Market The automotive fuse market is on a significant upward trajectory, driven by the rising production and sales of automobiles, particularly hybrid and electric vehicles. The demand stems not only from the increasing quantity of vehicles on the road but also from a growing concern for vehicle safety and efficiency. These factors are...

Continue Reading
Broadway Financial Corporation's Q1 2025 Financial Overview

Updated Category News Views 195

Broadway Financial Corporation's Financial Performance for Q1 2025 Broadway Financial Corporation (NASDAQ: BYFC), the parent company of City First Bank, recently shared its financial results for the first quarter of 2025. The company reported a consolidated net loss before preferred dividends of $451 thousand or ($0.05) per diluted share during this period. This is a...

Continue Reading
MOTHER Games Unveils Creative Teaser for Le Zoo's Launch

Updated Category News Views 323

Exciting Reveal from MOTHER Games for Le Zoo MOTHER Games, an innovative art and media company based in Brooklyn, has released an intriguing teaser for its upcoming indie game, Le Zoo. Scheduled to launch in 2025, this title promises to offer a unique and transformative gaming experience led by a talented team of industry professionals. The Essence of Le Zoo As players...

Continue Reading